They ok'd the Pfizer one and other regulatory bodies will too. They have zero links to the agents of those other vaccines and cant do other than give an objective evaluation. Can they do that for a vaccine that's produced by their own employers? The government have invested money and credibility into it.
We'll soon see.
The sketchy data they have right now, especially that concerning older age groups, look very unconvincing to be passing it.
There is no "sketchy data "
All the info I have seen is perfectly fine for a general vaccine.
The only other point is by accident they found it much better in a smaller dose and rightly so it was trialed in the upto 55 age group and quite rightly not to the vulnerable & elderly until its considered safe in the younger group , same as they have done with pregnant woman and children.
Of course this will take longer to pass , but it certainly is not " sketchy data ".